Edition:
United States

Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.41USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
498
52-wk High
$16.55
52-wk Low
$5.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.578
FY 2018 Dec '18 0.00 -0.405
Sep '18 0.00 -0.516
Jun '18 0.00 -0.458
Mar '18 0.00 -0.434
FY 2017 Dec '17 0.00 -0.363
Sep '17 0.00 -0.320
Jun '17 0.00 -0.351
Mar '17 0.00 -0.369
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.00 0.00 0.00 2.07
Year Ending Dec-20 5 2.89 11.43 0.00 36.40
Earnings (per share)
Quarter Ending Sep-19 6 -0.52 -0.42 -0.69 -0.50
Quarter Ending Dec-19 6 -0.57 -0.43 -0.90 -0.52
Year Ending Dec-19 6 -2.13 -1.80 -2.71 -2.12
Year Ending Dec-20 5 -1.98 -1.50 -2.73 -1.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.98 34.52
P/E High - Last 5 Yrs. -- 169.30 54.21
P/E Low - Last 5 Yrs. -- 53.46 28.29
Beta 0.51 1.29 0.99
Price to Sales (TTM) -- 42.23 7.97
Price to Book (MRQ) 1.81 12.30 4.45
Price to Tangible Book (MRQ) 1.85 17.07 5.18
Price to Cash Flow (TTM) -- 64.34 24.33
% Owned Institutions 69.92 3.23 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.63
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.85 6.83
Payout Ratio(TTM) -- 2.43 47.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 67.62 14.69
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 8.20
Sales - 5 Yr. Growth Rate -- 33.40 9.46
EPS (MRQ) vs Qtr. 1 Yr. Ago -33.20 -6.26 18.14
EPS (TTM) vs TTM 1 Yr. Ago -33.32 -- --
EPS - 5 Yr. Growth Rate -- 22.67 7.10
Capital Spending - 5 Yr. Growth Rate -- 26.51 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.79 2.54
Current Ratio (MRQ) 9.17 3.88 3.54
LT Debt to Equity (MRQ) 0.00 7.90 12.58
Total Debt to Equity (MRQ) 0.00 20.96 17.60
Interest Coverage (TTM) -- 31.43 14.89

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.23 50.19
Gross Margin - 5 Yr. Avg. -- 59.05 51.31
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -11.70 16.45
Operating Margin (TTM) -- -122.20 -6.60
Operating Margin - 5 Yr. Avg. -- -27.79 11.94
Pre-Tax Margin (TTM) -- -123.99 -6.95
Pre-Tax Margin - 5 Yr. Avg. -- -32.85 15.91
Net Profit Margin (TTM) -- -129.71 -10.73
Net Profit Margin - 5 Yr. Avg. -- -37.76 11.28
Effective Tax Rate (TTM) -- 17.16 20.55
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.50

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 10,321,994 879,617,670
Net Income/Employee (TTM) -2,427,380 2,332,961 102,957,990
Receivable Turnover (TTM) -- 12.39 5.90
Inventory Turnover (TTM) -- 2.40 3.64
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -71.56 6.42 10.25
Return on Assets - 5 Yr. Avg. -62.41 6.15 11.20
Return on Investment (TTM) -79.69 7.77 12.69
Return on Investment - 5 Yr. Avg. -68.39 8.01 14.18
Return on Equity (TTM) -80.57 8.27 17.17
Return on Equity - 5 Yr. Avg. -87.88 8.94 15.55
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -27.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aldeyra Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -28.98 -29.60 7 1
13 Week -32.09 -33.72 22 5
26 Week -40.79 -46.87 21 23
52 Week -34.53 -38.32 47 6
YTD -36.51 -46.53 20 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.92%
# of Holders: 108
Total Shares Held: 19,221,080
3 Mo. Net Change: -103,520
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 7
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.